» Articles » PMID: 28652670

Satisfaction with and Adherence to Warfarin Treatment: A Cross-sectional Study Among Sudanese Patients

Overview
Date 2017 Jun 28
PMID 28652670
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Satisfaction with and adherence to oral anticoagulant treatment are important measures that decrease morbidity and mortality. Higher satisfaction and adherence to warfarin therapy was found to be associated among other factors with good International Normalized Ratio (INR) control.

Objectives: To assess patient satisfaction with and adherence to oral anticoagulant therapy and to identify predictors of the two studied domains.

Methods: A cross-sectional study was conducted at the Cardiothoracic Clinic in Alshaab Teaching Hospital; Khartoum; Sudan during March-April 2015. A representative sample of patients on oral anticoagulant treatment was recruited. Data was collected through face-to-face interview method using oral Anti-Clot Treatment Scale (ATCS) to measure satisfaction and the 4-items Morisky Scale to measure adherence to therapy. Data was processed using SPSS. Logistic regression analysis was performed. P value <0.05 was considered statistically significant.

Results: A total of 93 patients was included, of them 46 were males. Overall, 47 (50.5%) were classified as satisfied with anti-clot treatment. Patients attained secondary and above educational level were approximately 8 times more satisfied with their anti-clot treatment, compared to those educated below this level, [OR 7.9 (2.9-21.7), P < 0.001]. Similarly, patients currently working were found to be approximately 3 times more satisfied with warfarin therapy, compared those who had no jobs, [OR 2.9 (1.1-7.6), P = 0.035]. Overall, 5.4% of the patients were found to be adherent to warfarin therapy. No definite background characteristic variable was found to be associated with adherence to treatment. No association was found between patient satisfaction and adherence to treatment, (P = 0.490).

Conclusions: Ensuring health education on warfarin together with continuous patients motivation are needed, specifically among patients with low educational level. Efficient multidisciplinary effort from all healthcare providers is needed to make warfarin treatment more successful.

Citing Articles

Knowledge, Adherence, and Satisfaction With Warfarin Therapy and Associated Factors Among Outpatients at University Teaching Hospital in Ethiopia.

Tadesse T, Yadeta D, Chelkeba L, Gebremedhin A, Gedif Fenta T Clin Appl Thromb Hemost. 2024; 30:10760296241260736.

PMID: 38863211 PMC: 11179514. DOI: 10.1177/10760296241260736.


Translation and validation of the Arabic version of the Morisky, Green and Levine (MGL) adherence scale.

Awwad O, AlMuhaissen S, Al-Nashwan A, AbuRuz S PLoS One. 2022; 17(10):e0275778.

PMID: 36206237 PMC: 9543961. DOI: 10.1371/journal.pone.0275778.


Effectiveness of a Nursing Intervention Module on Adherence, Knowledge, Quality of Life, and Complications Among Patients Receiving Anticoagulation therapy-a Randomized Controlled Trial Protocol.

Prameela DSouza J, Chakrabarty J, Ramachandran P, Guddattu V, Nayak B, George A Patient Prefer Adherence. 2022; 16:1723-1731.

PMID: 35903081 PMC: 9314451. DOI: 10.2147/PPA.S365585.


The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country.

Al-Jabi S, Dalu A, Koni A, Khdour M, Taha A, Amer R Thromb J. 2022; 20(1):15.

PMID: 35379235 PMC: 8978358. DOI: 10.1186/s12959-022-00374-2.


The Impact of a Pharmacist-led Warfarin Educational Video in a Saudi Setting.

Shilbayeh S J Pharm Bioallied Sci. 2021; 12(4):413-422.

PMID: 33679087 PMC: 7909055. DOI: 10.4103/jpbs.JPBS_188_20.


References
1.
Kuruvilla M, Gurk-Turner C . A review of warfarin dosing and monitoring. Proc (Bayl Univ Med Cent). 2005; 14(3):305-6. PMC: 1305837. DOI: 10.1080/08998280.2001.11927781. View

2.
Platt A, Russell Localio A, Brensinger C, Cruess D, Christie J, Gross R . Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf. 2008; 17(9):853-60. PMC: 2919157. DOI: 10.1002/pds.1556. View

3.
Kimmel S . Warfarin therapy: in need of improvement after all these years. Expert Opin Pharmacother. 2008; 9(5):677-86. PMC: 2855533. DOI: 10.1517/14656566.9.5.677. View

4.
Wieloch M, Sjalander A, Frykman V, Rosenqvist M, Eriksson N, Svensson P . Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA. Eur Heart J. 2011; 32(18):2282-9. DOI: 10.1093/eurheartj/ehr134. View

5.
Shikiar R, Rentz A . Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004; 7(2):204-15. DOI: 10.1111/j.1524-4733.2004.72252.x. View